Appendix K: Codes for Casefinding

Effective for Cases diagnosed between October 1, 2014 and September 30, 2015

Screening List of ICD-9-CM Codes for Casefinding

Certain ICD-9-CM* codes used by medical records departments for discharge diagnoses identify cases of malignant neoplasms that are reportable to the California Cancer Registry. Case finding procedures must include the review of medical records coded with the following numbers. Newly reportable diseases are followed by the ICD-O-3 morphology and behavior code in parentheses.

Note: Casefinding codes for borderline ovarian tumors (235.0-236.6) are included in the Supplementary List #2.

Historical ICD-9-CM Codes:

The following information is taken directly from the SEER web site:

http://seer.cancer.gov/tools/casefinding/case2014.html.

ICD-9-CM Casefinding List (Fiscal Year 2014: October 1, 2013 – September 30, 2014)

These tables are also available in a printable version (PDF):

http://seer.cancer.gov/tools/casefinding/fy2014-casefindinglist.pdf.

2014 Comprehensive ICD-9-CM Casefinding Code List for Reportable Tumors (Effective Date: 10/01/2013-09/30/2014)

Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List

ICD-9-CM Code*	Explanation of ICD-9-CM Code
140._ - 172._ 174._ - 209.36 209.7_	Malignant neoplasms (excluding category 173) , stated or presumed to be primary (of specified sites), and certain specified histologies
173.00 173.09	Unspecified/other malignant neoplasm of skin of lip
173.10 173.19	Unspecified/other malignant neoplasm of eyelid, including canthus
173.20 173.29	Unspecified/other malignant neoplasm of ear and external auricular canal
173.30 173.39	Unspecified/other malignant neoplasm of skin of other unspecified parts of face
173.40 173.49	Unspecified/other malignant neoplasm of scalp and skin of neck
173.50 173.59	Unspecified/other malignant neoplasm of skin of trunk, except scrotum
173.60 173.69	Unspecified/other malignant neoplasm of skin of upper limb, including shoulder
173.70 173.79	Unspecified/other malignant neoplasm of skin of lower limb, including hip
173.80 173.89	Unspecified/other malignant neoplasm of other specified sites of skin
173.90 173.99	Unspecified/other malignant neoplasm of skin, site unspecified
225.0 - 225.9	Benign neoplasm of brain and spinal cord neoplasm
227.3 227.4	Benign neoplasm of pituitary gland, craniopharyngeal duct (pouch) and pineal gland
228.02	Hemangioma; of intracranial structures
228.1	Lymphangioma, any site Note: Includes only lymphangioma of the brain, other parts of nervous system and endocrine gland
230.0 - 234.9	Carcinoma in situ
237.0 - 237.1	Neoplasm of uncertain behavior of endocrine glands and nervous system: pituitary gland, craniopharyngeal duct and pineal gland
237.5 237.6 237.9	Neoplasm of uncertain behavior of endocrine glands and nervous system: brain and spinal cord, meninges, endocrine glands and other and unspecified parts of nervous system
238.4	Polycythemia vera
238.7_	Other lymphatic and hematopoietic diseases
239.6 239.7	Neoplasms of unspecified nature, brain, endocrine glands and other parts of nervous system
273.3	Macroglobulinemia (Waldenstrom’s macroglobulinemia)
277.89	Other specified disorders of metabolism Reportable includes terms: Hand-Schuller-Christian disease; histiocytosis (acute)(chronic); histiocytosis X (chronic)

*Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant)

Return to top

SUPPLEMENTAL LIST ICD-9-CM* (EFFECTIVE DATES 10/1/2013-09/30/2014)

Note: Cases with these codes should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases.

ICD-9-CM Code*	Explanation of ICD-9-CM Code
042	Acquired Immunodeficiency Syndrome (AIDS) Note: Screen 042 for history of cancers with HIV/AIDS
079.51 79.53	Retrovirus (HTLV, types I, II and 2)
173.01 173.02	Basal and squamous cell carcinoma of skin of lip
173.11 173.12	Basal and squamous cell carcinoma of eyelid, including canthus
173.21 173.22	Basal and squamous cell carcinoma of ear and external auricular canal
173.31 173.32	Basal and squamous cell carcinoma of skin of other and unspecified parts of face
173.41 173.42	Basal and squamous cell carcinoma of scalp and skin of neck
173.51 173.52	Basal and squamous cell carcinoma of skin of trunk, except scrotum
173.61 173.62	Basal and squamous cell carcinoma of skin of upper limb, including shoulder
173.71 173.72	Basal and squamous cell carcinoma of skin of lower limb, including hip
173.81 173.82	Basal and squamous cell carcinoma of other specified sites of skin
173.91 173.92	Basal and squamous cell carcinoma of skin, site unspecified
209.40 - 209.69	Benign carcinoid tumors
210.0 - 229.9	Benign neoplasms (except for 225.0-225.9, 227.3, 227.4, 228.02, 228.1, which are listed in the Reportable list) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
235.0 - 236.99	Neoplasms of uncertain behavior Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
237.2 - 237.4	Neoplasm of uncertain behavior of adrenal gland, paraganglia and other and unspecified endocrine glands Note: screen for incorrectly coded malignancies or reportable by agreement tumors
237.7_	Neurofibromatosis and Schwannomastosis
238.0 - 239.9	Neoplasms of uncertain behavior (except for 238.4, 238.71-238.79, 239.6, 239.7, which are listed in the reportable list) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
259.2	Carcinoid syndrome
273.0	Polyclonal hypergammaglobulinemia Note: screen for blood disorders due to neoplasm
273.1	Monoclonal gammopathy of undetermined significance (9765/1) Note: Screen for incorrectly coded Waldenstrom macroglobulinemia or progression
273.2	Other paraproteinemias
273.8 273.9	Other and unspecified disorders of plasma protein metabolism Note: includes plasma disorders due to neoplastic disease
275.42	Hypercalcemia Note: Includes hypercalcium due to neoplastic disease
277.88	Tumor lysis syndrome (following neoplastic chemotherapy)
284.1_	Pancytopenia Note: screen for anemia disorder related to neoplasm
285.22	Anemia in neoplastic disease
285.3	Anemia due to antineoplastic chemotherapy
287.39 287.49 287.5	Secondary, other primary and unspecified thrombocytopenia Note: Screen for incorrectly coded thrombocythemia
288.03	Drug induced neutropenia Note: screen for anemia disorder related to neoplasm
288.3	Eosinophilia Note: This is the code for eosinophilia (9964/3). Not every case of eosinophilia is associated with a malignancy. Diagnosis must be “Hypereosonophilic syndrome” to be reportable
288.4	Hemophagocytic syndrome
338.3	Neoplasm related pain (acute)(chronic)
528.01	Mucositis due to antineoplastic therapy
530.85	Barrett’s esophagus (High grade dysplasia of esophagus)
569.44	Dysplasia of anus (Anal intraepithelial neoplasia [AIN I and II])
602.3	Dysplasia of prostate (Prostatic intraepithelial neoplasia [PIN I and II])
622.10-622.12	Dysplasia of cervix, unspecified and CIN I, CIN II
623.0	Dysplasia of vagina (Vaginal intraepithelial neoplasia [VAIN I and II])
624.01 624.02	Vulvar intraepithelial neoplasia: unspecified, VIN I and VIN II
630	Hydatidiform mole Note: This is a benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) and will have a malignancy code in the 140-209 range
780.79	Neoplastic (malignant) related fatigue
785.6	Enlargement of lymph nodes
789.51	Malignant ascites
790.93	Elevated prostate specific antigen (PSA)
793.8_	Nonspecific (abnormal) findings on radiological and examination of body structure (breast)
795.0_ - 795.1_	Papanicolaou smear of cervix and vagina with cytologic evidence of malignancy
796.7_	Abnormal cytologic smear of anus and anal HPV
795.8_	Abnormal tumor markers; Elevated tumor associated antigens [TAA]
963.1	Poisoning by primarily systemic agents: antineoplastic and immunosuppressive drugs
990	Effects of radiation, unspecified (radiation sickness)
999.3_	Complications due to central venous catheter
E858.0	Accidental poisoning by other drugs: Hormones and synthetic substitutes
E858.1	Accidental poisoning by other drugs: Primary systemic agents
E858.2	Agents primarily affecting blood constituents
E873.2	Failure in dosage, overdose of radiation in therapy (radiation sickness)
E879.2	Overdose of radiation given during therapy (radiation sickness)
E930.7	Adverse reaction of antineoplastic therapy-Antineoplastic antibiotics
E932.1	Adverse reaction to antineoplastic therapy-Androgens and anabolic congeners
E933.1	Adverse effect (poisoning) of immunosuppressive drugs
V10.0_ - V10.9_	Personal history of malignancy Note: Screen for recurrences, subsequent primaries, and/or subsequent treatment
V12.41	Personal history of benign neoplasm of the brain
V13.89	Personal history of unspecified malignant neoplasm and history of in-situ neoplasm of other site
V15.3	Other personal history presenting hazards to health or radiation Note: Personal history of therapeutic radiation
V42.81 V42.82	Organ or tissue replaced by transplant: Bone marrow, peripheral stem cell
V51.0	Encounter for breast reconstruction following mastectomy
V58.0 V58.1_	Encounter for radiotherapy, chemotherapy, immunotherapy
V66.1 V66.2	Convalescence and palliative care following radiotherapy, chemotherapy
V66.7	Encounter for palliative care
V67.1 V67.2	Follow up examination: following radiotherapy or chemotherapy
V71.1	Observation for suspected malignant neoplasm
V76._	Special screening for malignant neoplasms
V86 ._	Estrogen receptor positive status [ER+], negative status [ER-]
V87.41	Personal history of antineoplastic chemotherapy
V87.43	Personal history of estrogen therapy
V87.46	Personal history of immunosuppression therapy

Return to top

*International Classification of Diseases, 9th Revision, Clinical Modification, Sixth Edition, 2014.

<< Prev. Next >>